From: FiercePharma

By: Angus Liu

COVID-19 is Bad News for New Drug Launches. Which Will Suffer Most?

A recent survey by Spherix Global Insights showed that one-quarter of neurologists are less likely to prescribe a migraine therapy that has been on the market for less than a year due to the ongoing COVID-19 crisis… (read more).